NextCure Inc. (NXTC) - 5i Research

NextCure Inc. (NXTC $5.75)
- $5.75 Cap: $15M
- View NXTC Profile
- View Questions on NXTC

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Amgen Inc. (AMGN $279.50)
- $279.50 P/E (TTM): 23.43X Cap: $150.32B
- View AMGN Profile
- View Questions on AMGN
Regeneron Pharmaceuticals Inc. (REGN $578.29)
- $578.29 P/E (TTM): 14.29X Cap: $61.15B
- View REGN Profile
- View Questions on REGN
Vertex Pharmaceuticals Incorporated (VRTX $386.16)
- $386.16 P/E (TTM): 26.91X Cap: $96.56B
- View VRTX Profile
- View Questions on VRTX
iShares Biotechnology ETF (IBB $141.04)
- $141.04 P/E (TTM): 18.7X Cap: $5.66B
- View IBB Profile
- View Questions on IBB
Mettler-Toledo International Inc. (MTD $1,229.91)
- $1,229.91 P/E (TTM): 31.87X Cap: $25.58B
- View MTD Profile
- View Questions on MTD
Solid Biosciences Inc. (SLDB $6.14)
- $6.14 Cap: $485M
- View SLDB Profile
- View Questions on SLDB
TCR2 Therapeutics Inc. (TCRR)
- Cap: $58M
- View TCRR Profile
- View Questions on TCRR
NextCure Inc. (NXTC $5.75)
- $5.75 Cap: $15M
- View NXTC Profile
- View Questions on NXTC

Q: In an answer today you stated '20% of biotech companies in the US now trading below cash levels'. What would be your top biotech picks and/or your top biotech ETFs to play a recovery?

Read Answer Asked by Larry M. on May 11, 2022

NextCure Inc. (NXTC $5.75)
- $5.75 Cap: $15M
- View NXTC Profile
- View Questions on NXTC

Q: Can you comment about this US drug Co. developing immuno-medicines for Cancer.

Read Answer Asked by Vinod on November 15, 2019